# PEDIATRIC INCLUSION ALLIANCE hires LEAVITT PARTNERS, LLC (Health Issues, Medical/Disease Research/Clinical Labs)

**Score:** 60/100

| Field | Value |
|---|---|
| Client | PEDIATRIC INCLUSION ALLIANCE |
| Client description | A multi-sector, consensus-based policy and advocacy alliance. |
| Client state | DC |
| Lobbying firm | LEAVITT PARTNERS, LLC |
| Firm state | DC |
| Issue areas | Health Issues, Medical/Disease Research/Clinical Labs |
| Specific matters disclosed | As part of the upcoming reauthorization of FDAs medical product user fee programs, direct FDA to prioritize pediatric inclusion efforts by establishing clearer, more consistent policies and practices for including children in clinical trials as early as scientifically and ethically appropriate. · As part of the upcoming reauthorization of FDAs medical product user fee programs, direct FDA to prior |
| Registered | 2026-10-20 |

## Why this score
- Lobbying on several issue areas.
- Specific matters disclosed.

Source: U.S. Senate and House Lobbying Disclosure Act (LDA) filings via lda.gov; Colorado Secretary of State, NYC City Clerk eLobbyist and City of Chicago Board of Ethics lobbying data (https://lda.gov/filings/public/filing/5e4384b8-9d64-45f1-a36a-b745bb1090e8/print/). Last refreshed: 2026-11-04T21:45:03.363Z.
From public Lobbying Disclosure Act registrations (lda.gov) and Colorado, New York City and City of Chicago lobbying disclosures. Organization level only: we never list lobbyist, CEO or contact names, and clients whose name reads as a person are left out. Chicago amounts are lobbyist compensation reported for the quarter, summed by client. A registration reports intent to lobby; it is not evidence of wrongdoing.